Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Tisagenlecleucel CAR-T Cell Therapy in Secondary CNS Lymphoma.

Frigault MJ, Dietrich J, Martinez-Lage M, Leick M, Choi BD, DeFilipp Z, Chen YB, Abramson J, Crombie J, Armand P, Nayak L, Panzini C, Riley LS, Gallagher K, Maus M.

Blood. 2019 Jul 18. pii: blood.2019001694. doi: 10.1182/blood.2019001694. [Epub ahead of print]

PMID:
31320380
2.

Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?

Tom MC, Cahill DP, Buckner JC, Dietrich J, Parsons MW, Yu JS.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:133-145. doi: 10.1200/EDBK_238353. Epub 2019 May 17.

PMID:
31099638
3.

Treatment-Induced Brain Tissue Necrosis: A Clinical Challenge in Neuro-Oncology.

Winter SF, Loebel F, Loeffler J, Batchelor TT, Martinez-Lage M, Vajkoczy P, Dietrich J.

Neuro Oncol. 2019 Mar 4. pii: noz048. doi: 10.1093/neuonc/noz048. [Epub ahead of print]

PMID:
30828724
4.

Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells.

Karschnia P, Jordan JT, Forst DA, Arrillaga-Romany IC, Batchelor TT, Baehring JM, Clement NF, Gonzalez Castro LN, Herlopian A, Maus MV, Schwaiblmair MH, Soumerai JD, Takvorian RW, Hochberg EP, Barnes JA, Abramson JS, Frigault MJ, Dietrich J.

Blood. 2019 May 16;133(20):2212-2221. doi: 10.1182/blood-2018-12-893396. Epub 2019 Feb 26.

PMID:
30808634
5.

MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas.

Nayyar N, White MD, Gill CM, Lastrapes M, Bertalan M, Kaplan A, D'Andrea MR, Bihun I, Kaneb A, Dietrich J, Ferry JA, Martinez-Lage M, Giobbie-Hurder A, Borger DR, Rodriguez FJ, Frosch MP, Batchelor E, Hoang K, Kuter B, Fortin S, Holdhoff M, Cahill DP, Carter S, Brastianos PK, Batchelor TT.

Blood Adv. 2019 Feb 12;3(3):375-383. doi: 10.1182/bloodadvances.2018027672.

6.

Pharmacologic management of cognitive impairment induced by cancer therapy.

Karschnia P, Parsons MW, Dietrich J.

Lancet Oncol. 2019 Feb;20(2):e92-e102. doi: 10.1016/S1470-2045(18)30938-0. Review.

PMID:
30723041
7.

MRI findings in trigeminal neuropathy: bilateral Meckel's cave lesions.

Karschnia P, Sengupta S, Dietrich J.

Acta Neurol Belg. 2019 Feb 2. doi: 10.1007/s13760-019-01091-w. [Epub ahead of print] No abstract available.

PMID:
30712245
8.

Assessment and management of cognitive changes in patients with cancer.

Parsons MW, Dietrich J.

Cancer. 2019 Jun 15;125(12):1958-1962. doi: 10.1002/cncr.31905. Epub 2019 Jan 22. No abstract available.

PMID:
30668896
9.

Stuttering as the first sign of CAR-T-cell-related encephalopathy syndrome (CRES).

Gonzalez Castro LN, Dietrich J, Forst DA.

J Cancer Res Clin Oncol. 2019 Jul;145(7):1917-1918. doi: 10.1007/s00432-018-2818-y. Epub 2018 Dec 11. No abstract available.

PMID:
30539279
10.

Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide.

Dworkin M, Mehan W, Niemierko A, Kamran SC, Lamba N, Dietrich J, Martinez-Lage M, Oh KS, Batchelor TT, Wen PY, Loeffler JS, Shih HA.

J Neurooncol. 2019 Mar;142(1):69-77. doi: 10.1007/s11060-018-03063-1. Epub 2018 Nov 28.

PMID:
30488294
11.

Simulation of regional irrigation requirement with SWAT in different agro-climatic zones driven by observed climate and two reanalysis datasets.

Uniyal B, Dietrich J, Vu NQ, Jha MK, Arumí JL.

Sci Total Environ. 2019 Feb 1;649:846-865. doi: 10.1016/j.scitotenv.2018.08.248. Epub 2018 Aug 22.

PMID:
30176493
12.

Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic Study.

Ly KI, Oakley DH, Pine AB, Frosch MP, Chiou SH, Betensky RA, Pomerantz SR, Hochberg FH, Batchelor TT, Cahill DP, Dietrich J.

Oncologist. 2019 Mar;24(3):402-413. doi: 10.1634/theoncologist.2018-0086. Epub 2018 Aug 10.

PMID:
30097523
13.

EEG findings in CAR T-cell therapy-related encephalopathy.

Herlopian A, Dietrich J, Abramson JS, Cole AJ, Westover MB.

Neurology. 2018 Jul 31;91(5):227-229. doi: 10.1212/WNL.0000000000005910. Epub 2018 Jun 29. No abstract available.

14.

Bone marrow drives central nervous system regeneration after radiation injury.

Dietrich J, Baryawno N, Nayyar N, Valtis YK, Yang B, Ly I, Besnard A, Severe N, Gustafsson KU, Andronesi OC, Batchelor TT, Sahay A, Scadden DT.

J Clin Invest. 2018 Jun 1;128(6):2651. doi: 10.1172/JCI121592. Epub 2018 Jun 1. No abstract available.

15.

Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis.

Ahluwalia M, Barnett GH, Deng D, Tatter SB, Laxton AW, Mohammadi AM, Leuthardt E, Chamoun R, Judy K, Asher A, Essig M, Dietrich J, Chiang VL.

J Neurosurg. 2018 May 4;130(3):804-811. doi: 10.3171/2017.11.JNS171273.

PMID:
29726782
16.

Cosmology and fundamental physics with the Euclid satellite.

Amendola L, Appleby S, Avgoustidis A, Bacon D, Baker T, Baldi M, Bartolo N, Blanchard A, Bonvin C, Borgani S, Branchini E, Burrage C, Camera S, Carbone C, Casarini L, Cropper M, de Rham C, Dietrich JP, Di Porto C, Durrer R, Ealet A, Ferreira PG, Finelli F, García-Bellido J, Giannantonio T, Guzzo L, Heavens A, Heisenberg L, Heymans C, Hoekstra H, Hollenstein L, Holmes R, Hwang Z, Jahnke K, Kitching TD, Koivisto T, Kunz M, La Vacca G, Linder E, March M, Marra V, Martins C, Majerotto E, Markovic D, Marsh D, Marulli F, Massey R, Mellier Y, Montanari F, Mota DF, Nunes NJ, Percival W, Pettorino V, Porciani C, Quercellini C, Read J, Rinaldi M, Sapone D, Sawicki I, Scaramella R, Skordis C, Simpson F, Taylor A, Thomas S, Trotta R, Verde L, Vernizzi F, Vollmer A, Wang Y, Weller J, Zlosnik T; Euclid Theory Working Group.

Living Rev Relativ. 2018;21(1):2. doi: 10.1007/s41114-017-0010-3. Epub 2018 Apr 12. Review.

17.

Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate.

Andronesi OC, Arrillaga-Romany IC, Ly KI, Bogner W, Ratai EM, Reitz K, Iafrate AJ, Dietrich J, Gerstner ER, Chi AS, Rosen BR, Wen PY, Cahill DP, Batchelor TT.

Nat Commun. 2018 Apr 16;9(1):1474. doi: 10.1038/s41467-018-03905-6.

18.

Temozolomide therapy for aggressive functioning pituitary adenomas refractory to surgery and radiation: a case series.

Jordan JT, Miller JJ, Cushing T, Seijo M, Batchelor TT, Arrillaga-Romany IC, Shih HA, Nachtigall LB, Loeffler JS, Dietrich J.

Neurooncol Pract. 2018 Mar;5(1):64-68. doi: 10.1093/nop/npx013. Epub 2017 May 26.

19.

Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss.

Prust ML, Jafari-Khouzani K, Kalpathy-Cramer J, Polaskova P, Batchelor TT, Gerstner ER, Dietrich J.

Neuro Oncol. 2018 Jan 22;20(2):289-291. doi: 10.1093/neuonc/nox217. No abstract available.

20.

Neuroimaging of Brain Tumors: Pseudoprogression, Pseudoresponse, and Delayed Effects of Chemotherapy and Radiation.

Dietrich J, Winter SF, Klein JP.

Semin Neurol. 2017 Oct;37(5):589-596. doi: 10.1055/s-0037-1608657. Epub 2017 Dec 5. Review. No abstract available.

PMID:
29207418

Supplemental Content

Loading ...
Support Center